Tocilizumab for faster and safer remission of Takayasu's arteritis.

Authors:
Liao H; Du J; Li T; Pan L.

Journal:
Ther Adv Chronic Dis

Publication Year: 2022

DOI:
10.1177/20406223221131715

PMCID:
PMC9618741

PMID:
36324988

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Chronic Dis

Abbreviation: Ther Adv Chronic Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Aortic arch calcification increases major adverse cardiac event risk, modifiable by echocardiograph…
Chao CT; Liao MT; Wu CK. (2024) - Transparency Score: 3/6
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnosti…
Conigliaro P; D'Antonio A; Wlderk A and 7 more (2024) - Transparency Score: 3/6
Epidemiological characteristics, etiological spectrum, and outcomes of adult patients with pericard…
Farah Yusuf Mohamud M; Abdi IA; Uzel M and 5 more (2024) - Transparency Score: 3/6
Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules.
Shanazarov NA; Zare A; Mussin NM and 5 more (2024) - Transparency Score: 3/6
Prevalence of major non-communicable diseases and their associated risk factors in Afghanistan: a s…
Noormal AS; Winkler V; Bhusari SB and 8 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Natural Science Foundation of China (91739111 and 81400361). The fund providers played no role in the study design, data collection or analysis, decision to publish, or the preparation of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025